Page 119 - இந்தியன் சபை க்கு மருத்துவ ஆராய்ச்சி News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Questions over India’s Covaxin side effects, ethical violations Quartz 1/12/2021 A shadow is lurking over the trial process of India’s homegrown Covid-19 vaccine. Covaxin, the novel coronavirus vaccine co-developed by Bharat Biotech and the Indian Council for Medical Research, has been accused by some trial participants of sidestepping procedures and not making adverse events public. It has denied these charges, but trial volunteers want the government to intervene and halt the phase 3 human trials. Bharat Biotech began courting controversy on On Jan. 4, when scientists expressed grave concerns over the hasty approval given to Covaxin. Now, its trial participants in Madhya Pradesh’s Bhopal allege that they were not informed that the jab would be given to them as part of a clinical trial. Covaxin’s third phase of human trials has 25,800 participants across the country.

Madhya pradeshUnited kingdomHarsh vardhanGulabi deviRachna dhingraNarendra modiNausheen khanRashida beeInstitutional ethics committeePeople college of medical sciences research centreIndian council for medical researchSerum institute of indiaBharat biotechIndian councilMedical researchMedical sciences